Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,297–3,304 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Pfizer Inc. Sisunatovir - (REVIRAL1) Respiratory syncytial virus (RSV) infections in infants Phase 2 Oral Respiratory
Pfizer Inc. Tisotumab vedotin - (innovaTV 207) Squamous cell carcinoma of the head and neck (SCCHN) Phase 2 Data Released Intravenous Oncology
Pfizer Inc. SPR206 Multi-drug resistant (MDR) Gram-negative bacterial infections (renal impairment trial) Phase 2 Trial Discontinued Intravenous Antibiotic
Pfizer Inc. PTemanogrel Coronary Microvascular Obstruction (cMVO) Phase 2 Oral Cardiology
Pfizer Inc. PTemanogrel Coronary Microvascular Obstruction (cMVO) Phase 2 Oral Cardiology
Pfizer Inc. APD418 Acute heart failure (AHF) Phase 2 Intravenous Cardiology
Pfizer Inc. Etrasimod Alopecia areata (AA) Phase 2 Oral Immunology
Pfizer Inc. Darovasertib (IDE196), MEKTOVI (​binimetinib) and Crizotinib Metastatic uveal melanoma (MUM) Phase 2 Data Released Oral Oncology